ZENITH Expands US Presence
News Aug 19, 2016
ZENITH Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services.
Marking 10 years since the company first opened a US base in Pennsylvania, the new sites in Oakland and San Diego will help the life science technology firm deliver a more localized service to its North American customers.
Zenith Technologies’ clients range from small and mid-sized pharma and biotech companies to contract manufacturing organisations and big pharma firms.
The decision to open the new offices comes following an increase in demand for its automation manufacturing software systems and the significant biotech sector expansions in Southern and Northern California.
Mike Smith, US sales manager at Zenith Technologies said: “We are looking forward to bolstering our US presence with the opening of these two new sites as it means we can provide complete coverage of service in the US from coast to coast.
“Expanding into such high growth areas for the life science and biotechnology industry means it is a really exciting time for our company and a great way to mark a decade of presence in North America.”
Both offices will act as a hub for critical project aid, back office assistance and managed services, allowing Zenith Technologies to provide improved service and on-the-ground support to its customer base.
The company’s US expansion initially began as a single project in Pennsylvania in 2006 but has grown into six offices across the US and close to 100 employees servicing a diverse client base.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018